Evaxion A (EVAX) Other Non Operating Income (2020 - 2025)
Evaxion A (EVAX) reported Other Non Operating Income of -$45000.0 for Q2 2025, down 287.5% on a YoY basis from $24000.0 in Q2 2024, and down 287.5% quarter-over-quarter from $24000.0 in Q2 2024.
Evaxion A (EVAX) Other Non Operating Income (2020 - 2025) Analysis & Trends
Evaxion A has reported Other Non Operating Income for 6 years, with the latest figure at -$45000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -45,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Jun 30, 2023 | -9,000.00 |
| Jun 30, 2022 | -11,000.00 |
| Mar 31, 2022 | 18,000.00 |
| Sep 30, 2021 | -32,000.00 |
| Jun 30, 2021 | -57,000.00 |
| Mar 31, 2021 | 29,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Jun 30, 2020 | -10,000.00 |